Grown Rogue International (GRUSF) EBT Margin (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly EBT Margin of 18.53% for Q1 2026, down 3775.0% year-over-year from 0.5% in Q1 2025, and down 151.69% quarter-over-quarter from 35.85% in Q4 2025.
Grown Rogue International (GRUSF) EBT Margin (2009 - 2026) Analysis & Trends
Grown Rogue International's EBT Margin history runs 17 years deep, the most recent figure standing at 18.53% for Q1 2026.
- In Q1 2026, EBT Margin fell 3775.0% year-over-year to 18.53%; the TTM figure through Mar 2026 stood at 0.0% (down 2428409343.0% YoY), while the FY2025 annual figure was 1.58%, down 430.0% from the prior year.
- EBT Margin for Q1 2026 stood at 18.53%, down from 35.85% in the prior quarter.
- The five-year high for EBT Margin was 42163425.45% in Q4 2024, with the low at 7966355.51% in Q3 2024.
- The 5-year median for EBT Margin is 9.56% (2023), against an average of 2442645.78%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin jumped 2000000000 bps in 2024, then sank 2000000000 bps in 2025.
- Grown Rogue International's EBT Margin stood at 16.11% in 2022, then sank by 215 bps to 18.48% in 2023, then soared by 228120342 bps to 42163425.45% in 2024, then sank by 100 bps to 35.85% in 2025, then sank by 152 bps to 18.53% in 2026.
- Business Quant data shows GRUSF's EBT Margin at 18.53% in Q1 2026, 35.85% in Q4 2025, and 54.29% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -5.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.41% |
| Mar 31, 2026 | -18.53% |
| Dec 31, 2025 | 35.85% |
| Sep 30, 2025 | 54.29% |
| Mar 31, 2025 | 19.22% |
| Dec 31, 2024 | 42,163,425.45% |
| Sep 30, 2024 | -7,966,355.51% |
| Jun 30, 2024 | -90.97% |
| Mar 31, 2024 | -57.03% |
| Dec 31, 2023 | -18.48% |
| Oct 31, 2023 | -5.09% |
| Jul 31, 2023 | 8.60% |
| Apr 30, 2023 | 10.52% |
| Jan 31, 2023 | 16.47% |
| Jan 31, 2022 | 16.11% |
| Oct 31, 2021 | 43.06% |
| Jul 31, 2021 | 25.23% |
| Apr 30, 2021 | -38.13% |
| Jan 31, 2021 | 93.09% |
| Oct 31, 2020 | -57.76% |